The Biden administration announces the largest permanent increase in SNAP benefits history; a potential decision timeline on whether to offer COVID-19 booster shots to Americans may be on the horizon; children hospitalized with COVID-19 reaches a new record high.
The Biden administration is set to announce today revisions to the nutrition standards of the Supplemental Nutrition Assistance Program (SNAP) benefits program, formerly known as the Food Stamp Program, that will increase average benefits by more than 25% from prepandemic levels. Reported by The New York Times, all 42 million people enrolled in the program, or every 1 in 8 Americans, will receive additional aid, with average monthly benefits rising by $36 from $121 per person before the pandemic. This move marks the largest permanent increase in the program’s history
As reported by The Associated Press, the director of the National Institutes of Health, Francis Collins, MD, PhD, said yesterday that the decision on whether to offer COVID-19 booster shots to Americans could come this fall. Following the FDA’s decision to authorize an extra Pfizer or Moderna vaccine dose for immunocompromised individuals, data from preliminary studies in Israel on the Pfizer/BioNTech vaccine indicate that the vaccine’s protection against severe illness has diminished among those vaccinated in January. If expanded, the booster dose could go first to health care workers, nursing home residents, and other elderly people.
The amount of US children hospitalized with COVID-19 reached a record high of 1902 this past Saturday, with children currently accounting for 2.4% of the nation’s COVID-19 hospitalizations. Reported by Reuters, record highs in the number of patients newly hospitalized witg COVID-19 were also observed last week in individuals aged 18 to 29, 30 to 39, and 40 to 49 years. Notably, one-fifth of COVID-19 hospitalizations are in Florida, whose governor, Ron DeSantis, issued a ban on mask mandates in schools and across the state.
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based Care
May 26th 2023On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Listen
AHN’s Center for Inclusion Health Personalizing Equitable Care Delivery for Marginalized Communities
February 28th 2023On this episode of Managed Care Cast, we speak with Elizabeth Cuevas, MD, division chief of Allegheny Health Network’s (AHN) Center for Inclusion Health, on prevalent health inequities facing marginalized communities and strategies to identify and address these issues.
Listen
FDA Grants Accelerated Approval to Ponatinib Plus Chemotherapy in First-Line Ph+ ALL
March 19th 2024The FDA has granted accelerated approval to ponatinib (Iclusig) plus chemotherapy for the first-line treatment pf Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL).
Read More
6 Blood Biomarkers Identified to Predict CVD Risk in Patients With Rheumatoid Arthritis
March 15th 2024Baseline levels of serum amyloid A, C‐reactive protein, soluble tumor necrosis factor receptor 1, adiponectin, YKL‐40, and osteoprotegerin could be used to predict a rise in arterial inflammation.
Read More